Macquarie sets an AUD 55.60 target for Ramsay stock

Published on 10/20/2026 at 20:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 revenue rose 4.20 percent to AUD 18.6 billion. Ramsay stock costs EUR 33.70 on October 20, 2026, down 1.64 percent on ASX.

Macquarie target and Ramsay results

Macquarie set an AUD 55.60 target for Ramsay on October 19, 2026.
Fiscal 2026 revenue rose 4.20 percent to AUD 18.6 billion.
Ramsay stock costs EUR 33.70 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST, while ASX shares fell 1.64 percent.
The annual meeting is scheduled for November 24, 2026.

Ramsay, AU000000RHC8, Illustration mit AI erstellt.

Ramsay Health Care stock has an AUD 55.60 price target from Macquarie, while the company reported fiscal 2026 revenue growth of 4.20 percent. A Dow Jones item carried by Moomoo dated October 19, 2026 said Macquarie raised its target to AUD 55.60. The target is 2.77 percent above the ASX price of AUD 54.10 on October 20, 2026. At Lang & Schwarz, Ramsay was trading at EUR 33.70 on October 20, 2026 at 8:05 p.m. CEST, while the ASX price was down 1.64 percent versus its prior close.

Revenue growth supports the target

Ramsay reported fiscal 2026 revenue from contracts with customers of AUD 18.6 billion, up 4.20 percent from the prior year, according to the FinancialFilings reproduction of the annual report. Underlying net profit after tax and non-controlling interests increased 22.90 percent to AUD 364.1 million in fiscal 2026, while reported net profit attributable to owners reached AUD 329.2 million. The fully franked full-year dividend was AUD 0.91 per share, 13.80 percent above the prior period.

Price position and valuation

The ASX price of AUD 54.10 sat between the 52-week low of AUD 30.39 and high of AUD 55.98 on October 20, 2026. That places the stock 3.36 percent below its yearly high. Ramsay's price-to-earnings ratio was 39.78, compared with 15.53 for HCA Healthcare and 16.36 for Fresenius. Ramsay's market capitalization was AUD 12.5 billion, while HCA Healthcare stood at USD 100.5 billion and Fresenius at EUR 25.3 billion.

Two dates shape the next phase

Ramsay's annual general meeting and the meeting on the proposed Ramsay Sante demerger are scheduled for November 24, 2026. The Group Executive is due to hold an investor day on November 30, 2026, according to Ramsay's annual report. The proposed separation requires shareholder and regulatory approval, making those dates relevant to the company's portfolio simplification plan.

Comparison with peers

Ramsay Health Care: down 1.64 percent on the ASX, price-to-earnings ratio 39.78, market capitalization AUD 12.5 billion.

HCA Healthcare (NYSE, USD): up 2.05 percent, price-to-earnings ratio 15.53, market capitalization USD 100.5 billion.

Fresenius (Xetra, EUR): up 0.21 percent, price-to-earnings ratio 16.36, market capitalization EUR 25.3 billion.

What investors can measure next

Macquarie's AUD 55.60 target sits above the latest ASX price, while Ramsay's fiscal 2026 results show revenue growth and a higher dividend. The November 24 shareholder meetings and the November 30 investor day provide the next dated milestones for the proposed separation and operating strategy.

Ramsay was trading at EUR 33.70 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST. The ASX listing was down 1.64 percent against its prior close of October 19, 2026.

The further course of trading is shown by the continuously updated real-time quote of Ramsay stock.